Profile data is unavailable for this security.
About the company
U.S. Physical Therapy, Inc. is a national operator of outpatient physical therapy clinics and provider of industrial injury prevention services. Its physical therapy operations segment primarily operates through subsidiary clinic partnerships. Its physical therapy operations consist of physical therapy and occupational therapy clinics that provide pre- and post-operative care and treatment for orthopedic-related disorders, sports-related injuries, preventive care, rehabilitation of injured workers and neurological injuries. Services provided by the industrial injury prevention services segment include onsite injury prevention and rehabilitation, performance optimization, post-offer employment testing, functional evaluations and ergonomic assessments. It operates 687 outpatient physical therapy clinics in 42 states. In addition to owning and operating clinics, the Company manages 40 physical therapy facilities for unaffiliated third parties, including hospitals and physician groups.
- Revenue in USD (TTM)627.67m
- Net income in USD15.87m
- Incorporated1992
- Employees3.90k
- LocationUS Physical Therapy Inc1300 West Sam Houston Parkway, Suite 300HOUSTON 77043United StatesUSA
- Phone+1 (713) 297-7000
- Fax+1 (713) 297-7090
- Websitehttps://www.usph.com/
More ▼
Mergers & acquisitions
| Acquired company | USPH:NYQ since announced | Transaction value |
|---|---|---|
| Undisclosed Physical Therapy & Hand Therapy Practice(9) | -25.24% | 16.40m |
| Undisclosed Physical Therapy Practice(2) | -8.01% | 13.90m |
Data delayed at least 15 minutes, as of Sep 27 2024 23:59 BST.
Peer analysis
Key Information
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Fulgent Genetics Inc | 290.71m | -163.43m | 677.13m | 1.18k | -- | 0.5654 | -- | 2.33 | -5.48 | -5.48 | 9.72 | 37.42 | 0.2248 | -- | 6.36 | 245,527.90 | -13.20 | 16.70 | -13.96 | 18.37 | 39.10 | 67.89 | -58.73 | 29.06 | -- | -- | 0.0013 | 0.00 | -53.27 | 68.41 | -217.03 | -- | 57.08 | -- |
| Community Health Systems Inc | 12.55bn | -98.00m | 800.31m | 61.00k | -- | -- | 1.47 | 0.0638 | -0.7473 | -0.7473 | 95.60 | -10.37 | 0.8636 | 5.83 | 5.92 | 205,704.90 | 0.3717 | 0.7566 | 0.458 | 0.9381 | 84.44 | 83.69 | 0.4304 | 0.9345 | 1.32 | 1.19 | 1.08 | -- | 2.28 | -2.47 | -389.13 | -- | -2.39 | -- |
| InnovAge Holding Corp | 763.86m | -21.34m | 812.37m | 2.35k | -- | 3.03 | -- | 1.06 | -0.1571 | -0.1571 | 5.62 | 1.98 | 1.37 | -- | 21.09 | 325,044.70 | -4.17 | -3.72 | -5.96 | -4.90 | 17.29 | 20.39 | -3.04 | -2.79 | -- | -6.33 | 0.216 | -- | 11.01 | 10.41 | 47.54 | -- | -11.39 | -- |
| Pediatrix Medical Group Inc | 2.00bn | -251.89m | 923.06m | 2.90k | -- | 1.37 | -- | 0.461 | -3.04 | -3.04 | 24.13 | 8.24 | 0.9312 | -- | 7.35 | 690,500.70 | -11.71 | 0.8579 | -13.73 | 0.9945 | -- | -- | -12.58 | 1.52 | -- | 4.37 | 0.4715 | 0.00 | 1.15 | 2.97 | -196.55 | -- | 14.25 | -- |
| QDM International Inc | 4.07m | 1.08m | 933.00m | 5.00 | 1,037.74 | 289.51 | 830.18 | 229.17 | 0.0037 | 0.0037 | 0.014 | 0.0133 | 0.6732 | -- | 7.38 | 814,230.00 | 17.88 | -- | 31.49 | -- | 49.42 | -- | 26.56 | -- | -- | 866.35 | 0.267 | -- | 461.81 | -- | 3,411.87 | -- | -- | -- |
| GeneDx Holdings Corp | 243.66m | -117.47m | 1.02bn | 1.00k | -- | 5.94 | -- | 4.19 | -4.51 | -4.51 | 9.34 | 7.21 | 0.5631 | 9.82 | 8.37 | 243,657.00 | -27.15 | -- | -32.96 | -- | 55.97 | 11.50 | -48.21 | -121.10 | 2.22 | -7.19 | 0.2119 | -- | -13.69 | 8.72 | 67.98 | -- | 7.77 | -- |
| Aveanna Healthcare Holdings Inc | 1.95bn | -125.39m | 1.04bn | 3.50k | -- | -- | -- | 0.5334 | -0.6636 | -0.6636 | 10.15 | -0.6105 | 1.15 | -- | 7.38 | 557,846.30 | -7.36 | -- | -9.42 | -- | 30.72 | 31.12 | -6.42 | -12.71 | -- | 1.65 | 1.09 | -- | 6.02 | 8.62 | 79.68 | -- | -20.76 | -- |
| Pennant Group Inc | 611.81m | 19.33m | 1.04bn | 5.79k | 54.14 | 6.67 | 40.77 | 1.70 | 0.6352 | 0.6352 | 20.12 | 5.16 | 1.09 | -- | 9.18 | 105,647.70 | 3.60 | 1.81 | 4.27 | 2.14 | 20.46 | 21.62 | 3.29 | 1.92 | -- | 4.59 | 0.322 | 0.00 | 15.14 | 13.76 | 101.40 | -3.13 | 14.07 | -- |
| OPKO Health Inc | 716.37m | -243.10m | 1.09bn | 3.93k | -- | 0.7597 | -- | 1.53 | -0.3314 | -0.3314 | 0.9855 | 2.00 | 0.3462 | 7.92 | 4.53 | 182,282.70 | -11.75 | -7.14 | -13.16 | -8.14 | 25.98 | 34.42 | -33.93 | -13.83 | 1.36 | -5.84 | 0.1298 | -- | -14.01 | -2.70 | 42.49 | -- | -10.19 | -- |
| US Physical Therapy Inc | 627.67m | 15.87m | 1.27bn | 3.90k | 79.91 | 2.63 | 24.85 | 2.02 | 1.06 | 1.06 | 41.79 | 32.14 | 0.6206 | -- | 8.51 | 160,983.10 | 3.39 | 7.13 | 4.64 | 10.64 | 19.23 | 21.96 | 5.46 | 9.71 | -- | 67.92 | 0.1783 | 58.53 | 9.34 | 5.91 | -38.01 | 1.78 | 5.26 | 13.33 |
| Brookdale Senior Living, Inc. | 3.07bn | -207.25m | 1.31bn | 25.20k | -- | 3.82 | 8.78 | 0.4249 | -0.9181 | -0.9181 | 13.60 | 1.73 | 0.5411 | -- | 62.69 | 121,910.60 | -3.65 | -2.20 | -4.11 | -2.48 | 25.48 | 21.71 | -6.75 | -4.40 | -- | 0.224 | 0.9193 | -- | 6.74 | -7.82 | 20.73 | -- | -12.60 | -- |
| Agilon Health Inc | 5.12bn | -221.78m | 1.35bn | 1.12k | -- | 2.27 | -- | 0.2637 | -0.552 | -0.7438 | 12.60 | 1.64 | 2.27 | -- | 3.59 | 4,582,163.00 | -9.82 | -- | -25.09 | -- | 5.34 | -- | -4.33 | -- | -- | -- | 0.0507 | -- | 80.74 | -- | -112.01 | -- | -- | -- |
| Teladoc Health Inc | 2.61bn | -1.01bn | 1.40bn | 5.60k | -- | 0.9638 | -- | 0.5354 | -5.93 | -5.93 | 15.60 | 8.78 | 0.6656 | 22.10 | 12.04 | 465,953.60 | -25.65 | -33.54 | -30.82 | -34.63 | 70.80 | 68.59 | -38.54 | -171.39 | 1.62 | -- | 0.5063 | -- | 8.13 | 44.16 | 98.39 | -- | 79.43 | -- |
| Clover Health Investments Corp | 1.70bn | -127.94m | 1.49bn | 552.00 | -- | 4.18 | -- | 0.8773 | -0.2644 | -0.2557 | 3.48 | 0.6747 | 1.75 | -- | 5.70 | 3,071,556.00 | -13.24 | -- | -36.56 | -- | -- | -- | -7.55 | -- | -- | -19.35 | 0.00 | -- | -41.50 | -- | 37.03 | -- | -- | -- |
| AMN Healthcare Services, Inc. | 3.23bn | 99.23m | 1.75bn | 3.59k | 16.42 | 1.84 | 6.43 | 0.5415 | 2.59 | 2.59 | 84.58 | 23.08 | 1.19 | -- | 4.83 | 901,895.40 | 3.66 | 9.32 | 4.76 | 12.41 | 32.10 | 32.96 | 3.07 | 6.62 | -- | 3.10 | 0.5758 | 0.00 | -27.73 | 12.15 | -52.56 | 8.25 | 23.70 | -- |
Data as of Sep 27 2024. Currency figures normalised to US Physical Therapy Inc's reporting currency: US Dollar USD
58.71%Per cent of shares held by top holders
| Holder | Shares | % Held |
|---|---|---|
| BlackRock Fund Advisorsas of 31 Mar 2024 | 2.15m | 14.29% |
| Kayne Anderson Rudnick Investment Management LLCas of 31 Mar 2024 | 1.32m | 8.79% |
| The Vanguard Group, Inc.as of 31 Mar 2024 | 1.03m | 6.85% |
| Calvert Research & Managementas of 31 Mar 2024 | 800.38k | 5.31% |
| T. Rowe Price Investment Management, Inc.as of 31 Mar 2024 | 773.01k | 5.13% |
| Copeland Capital Management LLCas of 30 Jun 2024 | 765.67k | 5.08% |
| SSgA Funds Management, Inc.as of 31 Mar 2024 | 578.90k | 3.84% |
| Boston Trust Walden, Inc.as of 30 Jun 2024 | 544.72k | 3.62% |
| SouthernSun Asset Management LLCas of 31 Mar 2024 | 459.12k | 3.05% |
| Schroder Investment Management North America, Inc.as of 31 Mar 2024 | 415.34k | 2.76% |
More ▼
Data from 31 Mar 2024 - 30 Jun 2024Source: FactSet Research Systems Inc.
